Marshall Wace’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.06M | Buy |
+140,823
| New | +$3.06M | ﹤0.01% | 1263 |
|
|
2025
Q1 | – | Sell |
-253,637
| Closed | -$5.29M | – | 2533 |
|
|
2024
Q4 | $5.29M | Sell |
253,637
-607,297
| -71% | -$12.7M | 0.01% | 955 |
|
|
2024
Q3 | $17.1M | Sell |
860,934
-358,603
| -29% | -$7.13M | 0.02% | 510 |
|
|
2024
Q2 | $18.9M | Sell |
1,219,537
-464,414
| -28% | -$7.19M | 0.03% | 475 |
|
|
2024
Q1 | $26.8M | Buy |
+1,683,951
| New | +$26.8M | 0.04% | 367 |
|
|
2023
Q4 | – | Sell |
-73,991
| Closed | -$865K | – | 1899 |
|
|
2023
Q3 | $865K | Sell |
73,991
-120,012
| -62% | -$1.4M | ﹤0.01% | 1303 |
|
|
2023
Q2 | $2.61M | Buy |
+194,003
| New | +$2.61M | 0.01% | 1056 |
|
|
2022
Q1 | – | Sell |
-200,308
| Closed | -$1.36M | – | 2718 |
|
|
2021
Q4 | $1.36M | Buy |
+200,308
| New | +$1.36M | ﹤0.01% | 1780 |
|
|
2021
Q2 | – | Sell |
-103,332
| Closed | -$476K | – | 2166 |
|
|
2021
Q1 | $476K | Sell |
103,332
-38,466
| -27% | -$177K | ﹤0.01% | 1663 |
|
|
2020
Q4 | $474K | Sell |
141,798
-155,182
| -52% | -$519K | ﹤0.01% | 1343 |
|
|
2020
Q3 | $882K | Sell |
296,980
-32,450
| -10% | -$96.4K | 0.01% | 1033 |
|
|
2020
Q2 | $1.52M | Sell |
329,430
-775,996
| -70% | -$3.59M | 0.01% | 857 |
|
|
2020
Q1 | $4.26M | Sell |
1,105,426
-462,138
| -29% | -$1.78M | 0.04% | 418 |
|
|
2019
Q4 | $5.88M | Buy |
+1,567,564
| New | +$5.88M | 0.04% | 442 |
|